Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the approval of the drug on Thursday.

In a memo obtained by NPR, acting Health Secretary Dorothy Fink forbade staff from public communications on most matters until Feb. 1, unless they get express approval from "a presidential appointee."

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.

In a flurry of picks on Friday evening, Trump named three choices for top health jobs. Together they would help the incoming president shift the priorities of agencies that are key to public health.

Women across the U.S. will get a report with their mammogram results that tell them about their breast density assessment thanks to a new federal law that took effect this week.

Mammograms are a less effective diagnostic tool when a patient has dense breast tissue. Legislation headed to Gov. Eric Holcomb would require providers to notify patients of their breast tissue density.

Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.

Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.

The FDA will soon move to ban formaldehyde in hair-straightening products. It's more than a decade after research raised alarms about health risks and other worrying chemicals remain in the products.

Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns.